Table 2 Comparison of the prevalence of HPV16/18 infection relative to other HR-HPV types among 4345 patients [n(%)]
HPV type | N | Inflammation | CIN I | CIN II | CIN III | CC |
|---|---|---|---|---|---|---|
HPV16/18 (+) | 1666 | 139(8.34) | 213(12.79) | 345(20.71) | 434(26.05) | 535(32.11) |
HR-HPV (+) | 2679 | 371(13.85) | 427(15.94) | 721(26.91) | 604(22.55) | 556(20.75) |
\(\:{x}^{2}\) | 107.641 | |||||
P | <0.001 | |||||